TAMMY HIRSCHKORN: Open Payments
NPI 1477133783 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 34 payments from 8 companies in 2025. Trend: 2023 $887 · 2024 $546 · 2025 $501
Food & beverage: $389Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $152 |
| Alkermes, Inc. | 16 | $136 |
| Lundbeck LLC | 6 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| ABBVIE INC. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: REXULTI, ARISTADA, COBENFY, VIVITROL, AUSTEDO XR, UZEDY, LYBALVI, VRAYLAR.
Industry payments across TN — which companies pay providers there.
